Synlogic

SYBX NASDAQ
9.48
+1.76
+22.80%
已收盘, 19:52 06/17 EDT
开盘
7.76
昨收
7.72
最高
9.50
最低
7.60
成交量
43.65万
成交均量(3M)
11.59万
52周最高
14.59
52周最低
5.75
换手率
1.72%
市值
2.41亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Synlogic SYBX股票价格,Synlogic股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.
展开 >

最近浏览

名称
价格
涨跌幅